financetom
Business
financetom
/
Business
/
Moderna Gets FDA Approval For RSV Vaccine
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Moderna Gets FDA Approval For RSV Vaccine
May 31, 2024 8:37 AM

11:21 AM EDT, 05/31/2024 (MT Newswires) -- Moderna ( MRNA ) said Friday that the US Food and Drug Administration approved mRESVIA, the company's mRNA respiratory syncytial virus vaccine, that's designed to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection.

Price: 146.76, Change: -4.73, Percent Change: -3.12

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved